297 related articles for article (PubMed ID: 2536917)
1. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
2. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
3. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.
Gazdar AF; Carney DN; Nau MM; Minna JD
Cancer Res; 1985 Jun; 45(6):2924-30. PubMed ID: 2985258
[TBL] [Abstract][Full Text] [Related]
4. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD
Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922
[TBL] [Abstract][Full Text] [Related]
5. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
6. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD
J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer.
Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP
Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535
[TBL] [Abstract][Full Text] [Related]
8. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid.
Doyle LA; Giangiulo D; Hussain A; Park HJ; Yen RW; Borges M
Cancer Res; 1989 Dec; 49(23):6745-51. PubMed ID: 2555051
[TBL] [Abstract][Full Text] [Related]
10. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM
Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
[TBL] [Abstract][Full Text] [Related]
11. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
12. Expression of the c-myb oncogene in human small cell lung carcinoma.
Griffin CA; Baylin SB
Cancer Res; 1985 Jan; 45(1):272-5. PubMed ID: 2578097
[TBL] [Abstract][Full Text] [Related]
13. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
14. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.
Doyle LA; Mabry M; Stahel RA; Waibel R; Goldstein LH
Br J Cancer Suppl; 1991 Jun; 14():39-42. PubMed ID: 1645569
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer.
Bepler G; Jaques G; Havemann K; Koehler A; Johnson BE; Gazdar AF
Cancer Res; 1987 Apr; 47(7):1883-91. PubMed ID: 3028617
[TBL] [Abstract][Full Text] [Related]
16. [Recent progress in the biology of small cell bronchial carcinoma].
Thomas F; Arriagada R; Le Chevalier T; Poupon MF
Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257
[TBL] [Abstract][Full Text] [Related]
17. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p.
Graziano SL; Cowan BY; Carney DN; Bryke CR; Mitter NS; Johnson BE; Mark GE; Planas AT; Catino JJ; Comis RL
Cancer Res; 1987 Apr; 47(8):2148-55. PubMed ID: 3030544
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
[TBL] [Abstract][Full Text] [Related]
19. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.
Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K
Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
